Laser therapy of sebaceous hyperplasy

Outcome of treatment of sebaceous hyperplasy with CO2 laser therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201702016403N7

Enrollment

Registered

2017-04-17

Start date

2017-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?Sebaceous hyperplasy. Disorders of skin appendages

Interventions

Laser therapy.

Treatment - Devices

Laser therapy

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Clinically documented sebaceous hyperplasy Exclusion criteria: Pregnancy, breast feeding and skin repair disorder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement. Timepoint: The end of 2th week, 1th, 3th, 6th, 12th months. Method of measurement: clinical observation.	—

Secondary

Measure	Time frame
Complication( Hnfection, recurrence, scar, hyperpigmentation). Timepoint: The end 2 week, 1th, 3th, 6th and 12th months. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Dr Hossein Kavoussi

Kermanshah University of Medical Sciences

hkawosi@kums.ac.ir+98 83 3825 6643

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026